BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Overman MJ, Kopetz S, Lin E, Abbruzzese JL, Wolff RA. Is there a role for adjuvant therapy in resected adenocarcinoma of the small intestine. Acta Oncol. 2010;49:474-479. [PMID: 20397775 DOI: 10.3109/02841860903490051] [Cited by in Crossref: 55] [Cited by in F6Publishing: 44] [Article Influence: 4.6] [Reference Citation Analysis]
Number Citing Articles
1 Andromanakos N, Filippou D, Spiliadi C, Dimitrakopoulou A, Papachristodoulou A, Kostakis A. Synchronous primary duodenal bulb and cecal adenocarcinoma: case report and short review of the literature. Eur Surg 2012;44:200-3. [DOI: 10.1007/s10353-012-0079-6] [Reference Citation Analysis]
2 Yoshioka Y, Nozawa H, Tanaka J, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Hata K, Kazama S, Yamaguchi H, Ishihara S, Sunami E, Kitayama J, Watanabe T. Small bowel adenocarcinoma arising in a patient with hereditary hemorrhagic telangiectasia: A case report. Oncol Lett 2016;11:2137-9. [PMID: 26998137 DOI: 10.3892/ol.2016.4173] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
3 Chandrasegaram MD, Gill AJ, Samra J, Price T, Chen J, Fawcett J, Merrett ND. Ampullary cancer of intestinal origin and duodenal cancer - A logical clinical and therapeutic subgroup in periampullary cancer. World J Gastrointest Oncol 2017; 9(10): 407-415 [PMID: 29085567 DOI: 10.4251/wjgo.v9.i10.407] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 15] [Article Influence: 4.0] [Reference Citation Analysis]
4 Aparicio T, Zaanan A, Svrcek M, Laurent-Puig P, Carrere N, Manfredi S, Locher C, Afchain P. Small bowel adenocarcinoma: epidemiology, risk factors, diagnosis and treatment. Dig Liver Dis. 2014;46:97-104. [PMID: 23796552 DOI: 10.1016/j.dld.2013.04.013] [Cited by in Crossref: 142] [Cited by in F6Publishing: 105] [Article Influence: 15.8] [Reference Citation Analysis]
5 Aydin D, Sendur MA, Kefeli U, Unal OU, Tastekin D, Akyol M, Tanrikulu E, Ciltas A, Ustaalioglu BB, Uysal M, Esbag O, Yazilitas D, Tanrıverdi O, Bilici A, Arpaci E, Berk V, Yetisyigit T, Ozdemir NY, Oztop I, Alacacioglu A, Aydin O, Ozcelik M, Yildirim E, Dinc N, Gumus M. Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection. Clinical Colorectal Cancer 2017;16:220-7. [DOI: 10.1016/j.clcc.2016.08.002] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
6 Guo X, Mao Z, Su D, Jiang Z, Bai L. The clinical pathological features, diagnosis, treatment and prognosis of small intestine primary malignant tumors. Med Oncol. 2014;31:913. [PMID: 24639284 DOI: 10.1007/s12032-014-0913-8] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
7 Huffman BM, Jin Z, Yadav S, Patel S, Nagorney DM, Truty MJ, McWilliams RR, Halfdanarson TR, Mahipal A. Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma. Clin Colorectal Cancer 2019;18:218-25. [PMID: 31178274 DOI: 10.1016/j.clcc.2019.05.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
8 Zhang S, Yuan W, Zhang J, Chen Y, Zheng C, Ma J, Jiang Q, Zhao Y, Xu Q, Wang C. Clinicopathological features, surgical treatments, and survival outcomes of patients with small bowel adenocarcinoma. Medicine (Baltimore) 2017;96:e7713. [PMID: 28767610 DOI: 10.1097/MD.0000000000007713] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Egan L, D'Inca R, Jess T, Pellino G, Carbonnel F, Bokemeyer B, Harbord M, Nunes P, Van der Woude J, Selvaggi F, Triantafillidis J. Non-colorectal intestinal tract carcinomas in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (II). J Crohns Colitis 2014;8:19-30. [PMID: 23664498 DOI: 10.1016/j.crohns.2013.04.009] [Cited by in Crossref: 50] [Cited by in F6Publishing: 48] [Article Influence: 5.6] [Reference Citation Analysis]
10 Kitahara H, Honma Y, Ueno M, Kanemitsu Y, Ohkawa S, Mizusawa J, Furuse J, Shimada Y; Colorectal Cancer Study Group and Hepatobiliary and Pancreatic Oncology Group of the Japan Clinical Oncology Group. Randomized phase III trial of post-operative chemotherapy for patients with stage I/II/III small bowel adenocarcinoma (JCOG1502C, J-BALLAD). Jpn J Clin Oncol 2019;49:287-90. [PMID: 30590606 DOI: 10.1093/jjco/hyy188] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
11 Thiessen M, Lee-Ying RM, Monzon JG, Tang PA. An Examination of Lymph Node Sampling as a Predictor of Survival in Resected Node-Negative Small Bowel Adenocarcinoma: a SEER Database Analysis. J Gastrointest Cancer 2020;51:280-8. [PMID: 31111426 DOI: 10.1007/s12029-019-00250-9] [Reference Citation Analysis]
12 Arpa G, Grillo F, Giuffrida P, Nesi G, Klersy C, Mescoli C, Lenti MV, Lobascio G, Martino M, Latella G, Malvi D, Macciomei MC, Fociani P, Villanacci V, Rizzo A, Ferrero S, Sessa F, Orlandi A, Monteleone G, Biancone L, Cantoro L, Tonelli F, Ciardi A, Poggioli G, Rizzello F, Ardizzone S, Sampietro G, Solina G, Oreggia B, Papi C, D’incà R, Vecchi M, Caprioli F, Caronna R, D’errico A, Fiocca R, Rugge M, Corazza GR, Luinetti O, Paulli M, Solcia E, Di Sabatino A, Vanoli A. Separation of Low- Versus High-grade Crohn’s Disease-associated Small Bowel Carcinomas is Improved by Invasive Front Prognostic Marker Analysis. Journal of Crohn's and Colitis 2020;14:295-302. [DOI: 10.1093/ecco-jcc/jjz140] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
13 Nabais C, Salústio R, Sousa FV, Porto E, Cardoso C, Fradique C. Adenocarcinoma of the ileum: A rare and challenging entity. Ann Med Surg (Lond) 2015;4:116-8. [PMID: 25973190 DOI: 10.1016/j.amsu.2015.04.003] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
14 Nagaraj G, Zarbalian Y, Flora K, Tan BR Jr. Complete response and prolonged disease-free survival in a patient with recurrent duodenal adenocarcinoma treated with bevacizumab plus FOLFOX6. J Gastrointest Oncol 2014;5:E1-6. [PMID: 24490045 DOI: 10.3978/j.issn.2078-6891.2013.038] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
15 Aparicio T, Svrcek M, Zaanan A, Beohou E, Laforest A, Afchain P, Mitry E, Taieb J, Di Fiore F, Gornet JM, Thirot-Bidault A, Sobhani I, Malka D, Lecomte T, Locher C, Bonnetain F, Laurent-Puig P. Small bowel adenocarcinoma phenotyping, a clinicobiological prognostic study. Br J Cancer 2013;109:3057-66. [PMID: 24196786 DOI: 10.1038/bjc.2013.677] [Cited by in Crossref: 62] [Cited by in F6Publishing: 52] [Article Influence: 6.9] [Reference Citation Analysis]
16 Koo DH, Yun S, Hong YS, Ryu M, Lee J, Chang H, Kang Y, Kim S, Han D, Lee Y, Kim TW. Adjuvant Chemotherapy for Small Bowel Adenocarcinoma after Curative Surgery. Oncology 2011;80:208-13. [DOI: 10.1159/000328506] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
17 Gelsomino F, Balsano R, De Lorenzo S, Garajová I. Small Bowel Adenocarcinoma: From Molecular Insights to Clinical Management. Current Oncology 2022;29:1223-36. [DOI: 10.3390/curroncol29020104] [Reference Citation Analysis]
18 Legué LM, Bernards N, Gerritse SL, van Oudheusden TR, de Hingh IH, Creemers GM, Ten Tije AJ, Lemmens VE. Trends in incidence, treatment and survival of small bowel adenocarcinomas between 1999 and 2013: a population-based study in The Netherlands. Acta Oncol 2016;55:1183-9. [PMID: 27170100 DOI: 10.1080/0284186X.2016.1182211] [Cited by in Crossref: 24] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
19 Fallah J, Afari ME, Cordova AC, Olszewski AJ, Minami T. Small Bowel Adenocarcinoma as the Cause of Gastrointestinal Bleeding in Celiac Disease: A Rare Malignancy in a Common Disease. Case Rep Oncol Med 2015;2015:865383. [PMID: 26290763 DOI: 10.1155/2015/865383] [Reference Citation Analysis]
20 Khan K, Peckitt C, Sclafani F, Watkins D, Rao S, Starling N, Jain V, Trivedi S, Stanway S, Cunningham D. Prognostic factors and treatment outcomes in patients with Small Bowel Adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience. BMC Cancer. 2015;15:15. [PMID: 25603878 DOI: 10.1186/s12885-015-1014-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.6] [Reference Citation Analysis]
21 Akce M, Jiang R, Zakka K, Wu C, Alese OB, Shaib WL, Behera M, El-Rayes BF. Clinical Outcomes of Small Bowel Adenocarcinoma. Clin Colorectal Cancer 2019;18:257-68. [PMID: 31606297 DOI: 10.1016/j.clcc.2019.08.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
22 Raghav K, Overman MJ. Small bowel adenocarcinomas--existing evidence and evolving paradigms. Nat Rev Clin Oncol. 2013;10:534-544. [PMID: 23897080 DOI: 10.1038/nrclinonc.2013.132] [Cited by in Crossref: 86] [Cited by in F6Publishing: 70] [Article Influence: 9.6] [Reference Citation Analysis]
23 Tian J, Liu J, Guo C, Yang X, Yang Y, Gou H, Qiu M, Cao D. Prognostic factors and treatment outcomes in patients with non-ampullary small bowel adenocarcinoma: Long-term analysis. Medicine (Baltimore) 2019;98:e15381. [PMID: 31027129 DOI: 10.1097/MD.0000000000015381] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
24 Aquilanti FM, Barba MC, Bianciardi F, Tolu B, Nardiello B, Hamid Raza G, El Gawhary R, D'Ambrosio C, Gentile P. Stereotactic ablative radiation therapy as a potential curative treatment in duodenal adenocarcinoma: a case report. Tumori 2017;103:e31-3. [PMID: 28218383 DOI: 10.5301/tj.5000611] [Reference Citation Analysis]
25 Lancellotta V, Russo G, Lupattelli M, Iacco M, Perrucci E, Zucchetti C, Falcinelli L, Aristei C. Helical tomotherapy for duodenal adenocarcinoma in an elderly patient: A case report. World J Gastrointest Oncol 2017; 9(2): 94-97 [PMID: 28255431 DOI: 10.4251/wjgo.v9.i2.94] [Reference Citation Analysis]
26 Ecker B, Mcmillan M, Datta J, Dempsey D, Karakousis G, Fraker D, Drebin J, Mamtani R, Giantonio B, Roses R. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: A matched cohort study. European Journal of Cancer 2016;69:135-41. [DOI: 10.1016/j.ejca.2016.09.027] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 2.5] [Reference Citation Analysis]
27 Lech G, Korcz W, Kowalczyk E, Słotwiński R, Słodkowski M. Primary small bowel adenocarcinoma: current view on clinical features, risk and prognostic factors, treatment and outcome. Scand J Gastroenterol 2017;52:1194-202. [PMID: 28737049 DOI: 10.1080/00365521.2017.1356932] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
28 Paquissi FC, Lima AHFBP, Lopes MFDNV, Diaz FV. Adenocarcinoma of the third and fourth portions of the duodenum: The capsule endoscopy value. World J Gastroenterol 2015; 21(31): 9437-9441 [PMID: 26309371 DOI: 10.3748/wjg.v21.i31.9437] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
29 Oyasiji T, Alosi J, Tan W, Wilfong C, Wilkinson N. Duodenal Adenocarcinoma: Profile and Predictors of Survival Outcomes. The American Surgeon 2015;81:1125-33. [DOI: 10.1177/000313481508101124] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
30 Gleason D, Miller-hammond KE, Gibbs JF. Small Bowel Cancer. In: Chu QD, Gibbs JF, Zibari GB, editors. Surgical Oncology. New York: Springer; 2015. pp. 217-34. [DOI: 10.1007/978-1-4939-1423-4_10] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
31 Zhou YW, Xia RL, Chen YY, Ma XL, Liu JY. Clinical features, treatment, and prognosis of different histological types of primary small bowel adenocarcinoma: A propensity score matching analysis based on the SEER database. Eur J Surg Oncol 2021;47:2108-18. [PMID: 33849741 DOI: 10.1016/j.ejso.2021.03.260] [Reference Citation Analysis]
32 Aparicio T, Zaanan A, Mary F, Afchain P, Manfredi S, Evans TRJ. Small Bowel Adenocarcinoma. Gastroenterology Clinics of North America 2016;45:447-57. [DOI: 10.1016/j.gtc.2016.04.004] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 3.8] [Reference Citation Analysis]
33 Kothadia JP, Nagaraju DH, Katz S, Bruckner H, Itzkowitz SH, Schwartz M. Ileal Adenocarcinoma with Liver Metastasis in Patient with Crohn's Disease: A 9-Year Survival. Case Rep Oncol Med 2019;2019:8473829. [PMID: 31485362 DOI: 10.1155/2019/8473829] [Reference Citation Analysis]
34 Lee SY, Lee JH, Hwang DW, Kim SC, Park KM, Lee YJ. Long-term outcomes in patients with duodenal adenocarcinoma. ANZ J Surg 2014;84:970-5. [PMID: 23656271 DOI: 10.1111/ans.12112] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
35 Ye X, Zhang G, Chen H, Li Y. Meta-analysis of postoperative adjuvant therapy for small bowel adenocarcinoma. PLoS One 2018;13:e0200204. [PMID: 30096150 DOI: 10.1371/journal.pone.0200204] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Guo XC, Mao ZY, Su D, Wang LJ, Zhang TT, Bai L. Retrospective analysis of 119 small bowel adenocarcinoma in Chinese patients. Cancer Invest 2014;32:178-83. [PMID: 24654694 DOI: 10.3109/07357907.2014.896013] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
37 Widmar M, Greenstein AJ, Sachar DB, Harpaz N, Bauer JJ, Greenstein AJ. Small bowel adenocarcinoma in Crohn’s disease. J Gastrointest Surg. 2011;15:797-802. [PMID: 21336499 DOI: 10.1007/s11605-011-1441-x] [Cited by in Crossref: 29] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
38 Moekotte AL, Malleo G, van Roessel S, Bonds M, Halimi A, Zarantonello L, Napoli N, Dreyer SB, Wellner UF, Bolm L, Mavroeidis VK, Robinson S, Khalil K, Ferraro D, Mortimer MC, Harris S, Al-Sarireh B, Fusai GK, Roberts KJ, Fontana M, White SA, Soonawalla Z, Jamieson NB, Boggi U, Alseidi A, Shablak A, Wilmink JW, Primrose JN, Salvia R, Bassi C, Besselink MG, Abu Hilal M. Gemcitabine-based adjuvant chemotherapy in subtypes of ampullary adenocarcinoma: international propensity score-matched cohort study. Br J Surg 2020;107:1171-82. [PMID: 32259295 DOI: 10.1002/bjs.11555] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
39 Zindovic M, Culafic T, Saric D, Zindovic D. Adenocarcinoma of the Jejunum: A Case Report and Literature Review. Serbian Journal of Experimental and Clinical Research 2021;0:000010247820190079. [DOI: 10.2478/sjecr-2019-0079] [Reference Citation Analysis]
40 Maguire A, Sheahan K. Primary small bowel adenomas and adenocarcinomas-recent advances. Virchows Arch 2018;473:265-73. [PMID: 29998424 DOI: 10.1007/s00428-018-2400-7] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
41 Ecker BL, McMillan MT, Datta J, Mamtani R, Giantonio BJ, Dempsey DT, Fraker DL, Drebin JA, Karakousis GC, Roses RE. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: A propensity score-matched analysis. Cancer. 2016;122:693-701. [PMID: 26717303 DOI: 10.1002/cncr.29840] [Cited by in Crossref: 48] [Cited by in F6Publishing: 40] [Article Influence: 6.9] [Reference Citation Analysis]
42 Takayoshi K, Ariyama H, Tamura S, Yoda S, Arita T, Yamaguchi T, Ozono K, Yamamoto H, Inadomi K, Kumagai H, Tanaka M, Okumura Y, Sagara K, Nio K, Nakano M, Arita S, Kusaba H, Odashiro K, Oda Y, Akashi K, Baba E. Intraluminal superior vena cava metastasis from adenosquamous carcinoma of the duodenum: A case report. Oncol Lett 2016;11:605-9. [PMID: 26870254 DOI: 10.3892/ol.2015.3938] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
43 Schwameis K, Schoppmann SF, Stift J, Schwameis M, Stift A. Small bowel adenocarcinoma - terra incognita: A demand for cross-national pooling of data. Oncol Lett 2014;7:1613-7. [PMID: 24765188 DOI: 10.3892/ol.2014.1919] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
44 Duerr D, Ellard S, Zhai Y, Taylor M, Rao S. A Retrospective Review of Chemotherapy for Patients with Small Bowel Adenocarcinoma in British Columbia. J Cancer 2016;7:2290-5. [PMID: 27994666 DOI: 10.7150/jca.16606] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
45 Mizushima T, Tamagawa H, Mishima H, Ikeda K, Fujita S, Akamatsu H, Ikenaga M, Onishi T, Fukunaga M, Fukuzaki T, Hasegawa J, Takemasa I, Ikeda M, Yamamoto H, Sekimoto M, Nezu R, Doki Y, Mori M. The effects of chemotherapy on primary small bowel cancer: A retrospective multicenter observational study in Japan. Mol Clin Oncol 2013;1:820-4. [PMID: 24649253 DOI: 10.3892/mco.2013.150] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
46 Jabbour SK, Mulvihill D. Defining the role of adjuvant therapy: ampullary and duodenal adenocarcinoma. Semin Radiat Oncol. 2014;24:85-93. [PMID: 24635865 DOI: 10.1016/j.semradonc.2013.11.001] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.0] [Reference Citation Analysis]
47 Falcone R, Romiti A, Filetti M, Roberto M, Righini R, Botticelli A, Pilozzi E, Ghidini M, Pizzo C, Mazzuca F, Marchetti P. Impact of tumor site on the prognosis of small bowel adenocarcinoma. Tumori Journal 2019;105:524-8. [DOI: 10.1177/0300891619839297] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
48 Chen EY, Vaccaro GM. Small Bowel Adenocarcinoma. Clin Colon Rectal Surg 2018;31:267-77. [PMID: 30186048 DOI: 10.1055/s-0038-1660482] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
49 Ecker BL, McMillan MT, Datta J, Lee MK, Karakousis GC, Vollmer CM Jr, Drebin JA, Fraker DL, Roses RE. Adjuvant chemotherapy versus chemoradiotherapy in the management of patients with surgically resected duodenal adenocarcinoma: A propensity score-matched analysis of a nationwide clinical oncology database. Cancer. 2017;123:967-976. [PMID: 28263387 DOI: 10.1002/cncr.30439] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 3.2] [Reference Citation Analysis]